Micro-Coring for Skin Laxity

No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to explore Micro-Coring, a new treatment that might improve skin quality over the knees. Researchers seek to understand its effectiveness, safety, and patient satisfaction, particularly because knee skin differs from facial skin. Ideal candidates for this trial are those who notice loose skin around their knees and have not had recent knee surgery or specific skin treatments in that area. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research and potentially benefit from an innovative treatment.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on high doses of blood thinners or certain other medications like chemotherapy or high-dose corticosteroids. It's best to discuss your specific medications with the trial team.

What prior data suggests that Micro-Coring is safe for improving skin quality on the knees?

Research has shown that Micro-Coring is generally safe and well-tolerated for treating loose skin, wrinkles, and scars. Studies have found that using a device with tiny needles to remove small pieces of skin can improve the appearance of moderate to severe wrinkles. In these studies, patients experienced improvements with only minor side effects.

One study with 51 patients demonstrated a noticeable improvement in skin appearance, with minor side effects. These results suggest the procedure is safe, but more research is needed, especially for areas like the knees. Since body skin can differ from facial skin, healing and safety outcomes might vary.12345

Why are researchers excited about this trial?

Micro-Coring is unique because it offers a minimally invasive approach to treating skin laxity, particularly around the knees. Unlike traditional treatments like surgical lifts or laser therapy, Micro-Coring uses tiny needles to remove micro-cores of skin, which encourages natural skin tightening and rejuvenation without significant downtime. Researchers are excited about this technique because it holds the promise of achieving noticeable results with reduced recovery time and fewer risks compared to more invasive procedures.

What evidence suggests that Micro-Coring is effective for improving skin laxity on the knees?

Research has shown that Micro-Coring can greatly enhance skin quality. Clinical studies found a 91% improvement in moderate to severe wrinkles within six months of treatment. In another study, 85.7% of participants reported good to excellent improvements in loose skin and scars. This treatment removes up to 8% of the skin's volume in one session, leading to noticeable skin tightening after several treatments. The trial will specifically assess the effectiveness of Micro-Coring on the knees. Although early results suggest potential benefits for the knees, further research is necessary to confirm its effectiveness in that area.12678

Are You a Good Fit for This Trial?

This trial is for men and women aged 22 to 70 who have loose skin around their knees. Participants must be able to give written consent and follow the study's procedures and visits. It's not specified who can't join, but typically those with health issues affecting the treatment area might be excluded.

Inclusion Criteria

I am between 22 and 70 years old.
My doctor says I have loose skin over my knees.
I can and will sign a consent form and follow the study's requirements.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Micro-Coring treatment on the knees

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

90 days
1 visit (in-person) at 90 days

What Are the Treatments Tested in This Trial?

Interventions

  • Micro-Coring

Trial Overview

The trial is testing Micro-Coring®, a procedure that may improve skin quality around the knees. The study aims to understand how well it works, its safety, patient experience, ease of use, and best settings for treating body areas different from facial skin.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Micro-Coring on the kneesExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Cytrellis Biosystems, Inc.

Lead Sponsor

Trials
7
Recruited
180+

Citations

Effectiveness of Ellacor Treatment and When to See ...

Clinical studies support these testimonials, with data showing a 91% improvement in moderate to severe wrinkles within six months of treatment ...

Dermal Microcoring for Skin Laxity, Rhytides, and Scars

Among patients with adequate photographs for review, improvements of grade 3 and 4 (good and excellent) were seen in 85.7% (n = 18/21) treated ...

The Truth About Ellacor Micro-coring Treatments

As much as 8% of the skin's volume can be removed in a single session, and a series of treatments can create more significant skin tightening ...

Micro-Coring® for the Treatment of Skin Laxity of the Knees

Early, informal clinical experience suggests that Micro-Coring may help improve skin quality in certain body areas, such as the knees. However, this body region ...

Wrinkle Reduction - ellacor® Facial Skin Tightening

... Micro-Coring™ can improve mild to moderate skin laxity and sagging along the jawline, cheeks, jowls, and chin. The stainless-steel micro ...

Evaluation of Safety and Efficacy of Micro-coring Device for ...

A pilot study is designed to evaluate safety and efficacy of the Micro-Coring (MC) technology for treatment of facial wrinkles. MC device employs hollow coring ...

Micro-Coring® Procedure

Ellacor uses hollow needles to remove micro-cores of skin, resulting in an improved appearance of moderate and severe wrinkles in the mid and lower face.

Expect Ellacor's applications to be wide-ranging, expert ...

According to pivotal clinical data from Cytrellis on 51 patients treated with Ellacor, patients experienced a mean 1.3-grade improvement on the ...